Additional file 1 of Effectiveness of the BNT162b2 (Pfizer-BioNTech) and the ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccines for reducing susceptibility to infection with the Delta variant (B.1.617.2) of SARS-CoV-2 (2022)

First Author: Pattni K

Attributed to: Impact of network-structured populations on evolution funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.6084/m9.figshare.19388922

Publication URI: https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_of_Effectiveness_of_the_BNT162b2_Pfizer-BioNTech_and_the_ChAdOx1_nCoV-19_Oxford-AstraZeneca_vaccines_for_reducing_susceptibility_to_infection_with_the_Delta_variant_B_1_617_2_of_SARS-CoV-2/19388922

Type: Other